|
The NIH Awards Aciont® a Small Business Catalyst Award Grant Accelerating Innovative Research -
07/07/2010
Aciont is awarded a phase I SBIR $214K grant for the project titled "Novel Method for the Ocular Iontophoretic Delivery of Avastin® and Lucentis®"
|
| |
|
Aciont® CEO to Present at IN3 East Medical Device Conference -
06/01/2010
John Higuchi will present on behalf of Aciont Inc at the IN3 East Medical Device Conference in Boston, MA on June 10, 2010.
To see what will be presented on behalf of Aciont Inc, paste in the following link:
http://www.aciont.com/file/view/in3_aciont_summary_0610-pdf
|
| |
|
Aciont® To Present at ARVO 2010 Annual Meeting -
04/09/2010
Aciont’s poster “Transscleral Passive Delivery of Rapamycin in Rabbit Using a Visulex Topical Application Device” will be shown on May 6, 2010 at the ARVO Annual Meeting in Fort Lauderdale, FL.
|
| |
|
Aciont® Strengthens Management Team with Industry Leader in Ophthalmic Product Development -
04/02/2010
Balbir Brar brings 25 years of drug and device development experience to Aciont Inc.
|
| |
|
NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont® -
12/10/2009
The National Eye Institute (NEI) awarded a $2.18 million grant to Aciont Inc. to help fund its development of a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis.
|
| |
|
Visulex Macromolecule Research Article -
05/04/2009
A peer reviewed journal published an article presenting research from
a study which used Aciont’s Visulex® ocular iontophoretic system in the non-invasive delivery of a macromolecule. The article presents the clearance, migration, and distribution data of GalbuminTM following ocular iontophoretic Visulex treatment.
|
| |
|
Aciont ARVO 2009 Presentations Article -
05/04/2009
Aciont Inc. will present two of its Visulex® passive diffusion based topical application technologies at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting at the Greater Fort Lauderdale Convention Center.
|
| |
|
Tribute to William I. Higuchi in Journal of Pharmaceutical Sciences -
01/15/2008
Dr. Higuchi's contributions have significantly elevated the field of pharmaceutics. He has an impressive body of scientific work and a continuing legacy of his accomplishments.
|
| |
|
Aciont's Research Discussed in Two Recent Ophthalmic Publications -
11/21/2008
Aciont's research is published in Investigative Ophthalmology & Visual Science journal and Journal of Ocular Pharmacology and Therapeutics.
|
| |
|
NEI Awards Ocular Iontophoresis Research Grant to Aciont® Collaborators -
01/18/2007
Understanding of ocular pharmacokinetics and transport barriers of the eye would be a major step toward achieving a non-invasive drug delivery system to treat posterior segment of eye diseases.
|
| |
|
Aciont® Featured in Retina Today Article -
03/01/2007
Dr. Karl G. Csaky's article features new and exciting technologies in transscleral drug delivery.
|
| |
|
Aciont Announces SBIR Funding to Support the Development of its Back-of-the-Eye Therapy Technology - November 2004 -
11/09/2004
|
| |
|
Aciont's Visulex Technology Highlighted in Leading Drug Delivey Trade Magazine -
04/15/2004
Advancing iontophoresis for effective noninvasive back-of-the-eye therapeutics.
|
| |
|
Aciont® Featured in Digital IQ Article -
06/04/2003
|
| |
|
Dr. Saettone's Ophthalmic Drug Delivery Report -
06/15/2002
Progress and problems in ocular drug delivery with discussions on: Drug absorption, Traditional ophthalmic vehicles, More efficient delivery, In-situ activated gel-forming systems, Mucoadhesive formulations, Inserts, and Ocular Penetration Enhancers.
|
| |
|
Aciont® Inc Awarded NIH Grant -
04/25/2002
Awarded a Phase-I Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH) for $100,000 payment based on the competitive merit of Aciont's proposal and technology.
|
| |
News Page
Executive Summary